Regulus execs expect $120M exit pay from Novartis takeovernews2025-05-27T18:45:10+00:00May 27th, 2025|Endpoints News|
Lilly to buy non-opioid pain biotech SiteOne for up to $1Bnews2025-05-27T15:02:17+00:00May 27th, 2025|Endpoints News|
Biogen taps City Therapeutics in RNAi deal worth up to $1Bnews2025-05-27T13:19:48+00:00May 27th, 2025|Endpoints News|
Blackstone’s GRIN inks epilepsy licensing deal with Angelini, closes $140M Series Dnews2025-05-27T12:30:28+00:00May 27th, 2025|Endpoints News|
TCG’s R&D venture team makes a T cell engager deal with Shanghai biotechnews2025-05-27T10:00:57+00:00May 27th, 2025|Endpoints News|
Hinge Health pops 23% as the digital health IPO market reawakensnews2025-05-22T17:26:25+00:00May 22nd, 2025|Endpoints News|
Sanofi makes $470M move for Vigil’s Alzheimer’s drug, while another asset returns to Amgennews2025-05-22T08:15:14+00:00May 22nd, 2025|Endpoints News|
BioNTech invests £1B in growing UK footprint under expanded pact with governmentnews2025-05-21T15:04:51+00:00May 21st, 2025|Endpoints News|
Genentech expands partnership with molecular glue biotech Orionisnews2025-05-21T11:00:29+00:00May 21st, 2025|Endpoints News|
Altos Labs buys anti-aging startup Dorian Therapeuticsnews2025-05-21T08:26:22+00:00May 21st, 2025|Endpoints News|
